Marjolijn J L Ligtenberg

Radboud University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Jack A. Schalken

NETHERLANDS

View details

Niven Mehra

Radboud University Medical Center

NETHERLANDS

View details

Marian J.E. Mourits

Professor

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Janet R. Vos

Radboud University Medical Center

NETHERLANDS

View details

Gerald Verhaegh

Radboud University Medical Center

NETHERLANDS

View details

Ed Schuuring

University Medical Center Groningen

NETHERLANDS

View details

nicoline hoogerbrugge

MD, Professor Hereditary Cancer

Radboud University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marjolijn J L Ligtenberg

Research Interests

Explore related searches

Contact this professor

Articles (10)

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups

PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancer

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer

Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands

Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing

Collaborators (7)

Jack A. Schalken

Niven Mehra

Marian J.E. Mourits

Janet R. Vos

Gerald Verhaegh

Ed Schuuring

nicoline hoogerbrugge

Make your next move.